453 related articles for article (PubMed ID: 18173204)
1. [Anticardiolipin antibodies in patients with systemic lupus erythematosus].
Petrović R; Petrović M; Novicić-Sasić D; Damjanov N
Srp Arh Celok Lek; 1994; 122 Suppl 1():98-100. PubMed ID: 18173204
[TBL] [Abstract][Full Text] [Related]
2. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
3. [Anticardiolipin antibodies in systemic lupus erythematosus: prevalence and clinical associations].
Abumohor P; Cerda C; Neira O; Palma S; Alvarado MA; Basualdo J; Bravo M; Guzmán L
Rev Med Chil; 1991 May; 119(5):517-23. PubMed ID: 1844289
[TBL] [Abstract][Full Text] [Related]
4. The course of anticardiolipin antibody levels under immunoadsorption therapy.
Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
[TBL] [Abstract][Full Text] [Related]
5. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus.
Loizou S; Byron MA; Englert HJ; David J; Hughes GR; Walport MJ
Q J Med; 1988 Jul; 68(255):525-31. PubMed ID: 3252304
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus].
Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G
Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Khamashta MA; Amengual O; Hughes GR
J Rheumatol; 1998 Jun; 25(6):1104-8. PubMed ID: 9632071
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
Sherer Y; Gerli R; Vaudo G; Schillaci G; Gilburd B; Giordano A; Bocci EB; Allegrucci R; Marchesi S; Mannarino E; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
[TBL] [Abstract][Full Text] [Related]
10. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE
Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
[TBL] [Abstract][Full Text] [Related]
11. [Anticardiolipin antibodies in rheumatic autoimmune diseases. Correlation with clinical and laboratory findings].
Llanos C; Inostroza J; Riedemann P; Ponce L; Kaliski S; Graf D; Aguayo O
Rev Med Chil; 1992 Nov; 120(11):1235-40. PubMed ID: 1340942
[TBL] [Abstract][Full Text] [Related]
12. Lupus anticoagulant and anticardiolipin antibodies in systemic lupus erythematosus.
Saxena R; Saraya AK; Dhot PS; Singh Y; Malaviya AN
Natl Med J India; 1994; 7(4):163-5. PubMed ID: 7950946
[TBL] [Abstract][Full Text] [Related]
13. [The prediction of thrombosis development in patients with systemic lupus erythematosus: the role of antibodies to cardiolipin].
Nasonov EL; Kovalev VIu; Alekberova ZS; Solov'ev SK
Ter Arkh; 1992; 64(5):25-30. PubMed ID: 1455369
[TBL] [Abstract][Full Text] [Related]
14. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
15. Anticardiolipin antibodies in acquired immunodeficiency syndrome.
Stimmler MM; Quismorio FP; McGehee WG; Boylen T; Sharma OP
Arch Intern Med; 1989 Aug; 149(8):1833-5. PubMed ID: 2504122
[TBL] [Abstract][Full Text] [Related]
16. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.
Sebastiani GD; Galeazzi M; Tincani A; Piette JC; Font J; Allegri F; Mathieu A; Smolen J; de Ramon Garrido E; Fernandez-Nebro A; Jedryka-Goral A; Papasteriades C; Morozzi G; Bellisai F; De Pitá O; Marcolongo R
Scand J Rheumatol; 1999; 28(6):344-51. PubMed ID: 10665739
[TBL] [Abstract][Full Text] [Related]
17. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus.
Hanly JG; Hong C; Smith S; Fisk JD
Arthritis Rheum; 1999 Apr; 42(4):728-34. PubMed ID: 10211887
[TBL] [Abstract][Full Text] [Related]
18. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
Sipek-Dolnicar A; Hojnik M; Rozman B; Vizjak A; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):707-10. PubMed ID: 11020961
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
